Home
>
National Drug Code (NDC)
>
RESTASIS
RESTASIS - 0023-9163-30 - (cyclosporine)
Drug Information of RESTASIS
| Product NDC: | 0023-9163 |
| Proprietary Name: | RESTASIS |
| Non Proprietary Name: | cyclosporine |
| Active Ingredient(s): | .5 mg/mL & nbsp; cyclosporine |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | EMULSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of RESTASIS
| Product NDC: | 0023-9163 |
| Labeler Name: | Allergan, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050790 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20030401 |
Package Information of RESTASIS
| Package NDC: | 0023-9163-30 |
| Package Description: | 30 VIAL, SINGLE-USE in 1 TRAY (0023-9163-30) > .4 mL in 1 VIAL, SINGLE-USE |
NDC Information of RESTASIS
| NDC Code | 0023-9163-30 |
| Proprietary Name | RESTASIS |
| Package Description | 30 VIAL, SINGLE-USE in 1 TRAY (0023-9163-30) > .4 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 0023-9163 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cyclosporine |
| Dosage Form Name | EMULSION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20030401 |
| Marketing Category Name | NDA |
| Labeler Name | Allergan, Inc. |
| Substance Name | CYCLOSPORINE |
| Strength Number | .5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |
